Published in

BioMed Central, BMC Infectious Diseases, 1(12), 2012

DOI: 10.1186/1471-2334-12-179

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Journal article published in 2012 by Stefano Rusconi ORCID, Vania Giacomet, Chiara Mameli, Alessandra Viganò, Ottavia Viganò, Fulvio Adorni ORCID, Massimo Galli, Gian Vincenzo Zuccotti ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO